On Monday, Google Inc. stated that its health-care research unit
reached an agreement to work with European pharmaceutical major Sanofi SA on
new ways to treat and monitor diabetes. The Wall
Street Journal has the
story:
Sanofi is a leading maker of diabetes medication, as well as
many other drugs. Google’s Life Sciences division is working on small,
connected medical devices to continuously collect diabetes-related data, as
well as software that learns from the information to find new treatments.
Diabetes is expected to affect 592 million people world-wide by 2035, according
to the International Diabetes Federation.
Google Life Sciences, led by Andrew Conrad, started about two
years ago as part of the company’s ambitious goal to expand beyond its Internet
search roots into big industries such as health care and transportation. Some
of these efforts have stumbled, but Google Life Sciences has made steady
progress through in-house research and partnerships with companies such as
Novartis AG and Biogen Inc.
The life-sciences division will become a stand-alone unit in
Google’s planned reorganization into a holding company called Alphabet Inc.
Some of the coolest sci-fi sounding
developments in store?
A Google-designed contact lens that measures
the glucose level in tears of diabetics, as well as a cheap, disposable device
the size of a Band-Aid to be worn on the skin to send blood-sugar measurements
to a smartphone.
www.technofighterss.blogspot.com
0 comments:
Post a Comment